RT Journal Article
T1 A Pilot Study Using Intratympanic Methylprednisolone for Treatment of Persistent Posterior Canal Benign Paroxysmal Positional Vertigo.
A1 Perez, Paz
A1 Franco, Virginia
A1 Oliva, Manuel
A1 Lopez Escamez, Jose A
K1 Benign paroxysmal positional vertigo
K1 intratympanic injection
K1 methylprednisolone
AB To assess the effect of intratympanic methylprednisolone (ITMP) in posterior canal benign paroxysmal positional vertigo (BPPV) that fails treatment involving repositioning maneuver in a case series. Nine patients with persistent posterior canal BPPV after 6 or more repositioning maneuvers were treated by ITMP (two weekly doses of 0.3-0.4 mL at 40 mg/mL) before repeating the repositioning procedures. Following ITMP treatment, 7 out of 9 patients were relieved of their symptoms and did not exhibit positional nystagmus after 1 or 2 repositioning maneuvers. The number of positional maneuvers performed before and after ITMP treatment in these 7 patients showed a statistically significant (p=0.016) reduction in the amount of repositioning treatments required. None of the 7 respondent patients showed any relapses during the follow-up period (follow-up range: 11-95 months). Administering ITMP before resuming repositioning procedures can be a useful treatment for persistent BPPV of the posterior canal.
PB Mediterranean Society of Otology and Neuro-Otology
SN 1308-7649
YR 2019
FD 2019-09-03
LK http://hdl.handle.net/10668/10650
UL http://hdl.handle.net/10668/10650
LA en
NO Pérez P, Franco V, Oliva M, López Escámez JA. A Pilot Study Using Intratympanic Methylprednisolone for Treatment of Persistent Posterior Canal Benign Paroxysmal Positional Vertigo. J Int Adv Otol. 2016 Dec;12(3):321-325.
DS RISalud
RD Apr 19, 2025